Literature DB >> 14595069

Human milk, breastfeeding, and transmission of human immunodeficiency virus type 1 in the United States. American Academy of Pediatrics Committee on Pediatric AIDS.

Jennifer S Read.   

Abstract

Transmission of human immunodeficiency virus type 1 (HIV-1) through breastfeeding has been conclusively demonstrated. The risk of such transmission has been quantified, the timing has been clarified, and certain risk factors for breastfeeding transmission have been identified. In areas where infant formula is accessible, affordable, safe, and sustainable, avoidance of breastfeeding has represented one of the main components of mother-to-child HIV-1 transmission prevention efforts for many years. In areas where affordable and safe alternatives to breastfeeding may not be available, interventions to prevent breastfeeding transmission are being investigated. Complete avoidance of breastfeeding by HIV-1-infected women has been recommended by the American Academy of Pediatrics and the Centers for Disease Control and Prevention and remains the only means by which prevention of breastfeeding transmission of HIV-1 can be absolutely ensured. This technical report summarizes the information available regarding breastfeeding transmission of HIV-1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14595069     DOI: 10.1542/peds.112.5.1196

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  20 in total

1.  Maternal infectious diseases, antimicrobial therapy or immunizations: very few contraindications to breastfeeding.

Authors: 
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

2.  High cell-free virus load and robust autologous humoral immune responses in breast milk of simian immunodeficiency virus-infected african green monkeys.

Authors:  Andrew B Wilks; James R Perry; Elizabeth P Ehlinger; Roland C Zahn; Robert White; Marie-Claire Gauduin; Angela Carville; Michael S Seaman; Joern E Schmitz; Sallie R Permar
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

3.  Maternal infectious diseases, antimicrobial therapy or immunizations: Very few contraindications to breastfeeding.

Authors: 
Journal:  Paediatr Child Health       Date:  2006-10       Impact factor: 2.253

4.  Care of the HIV-exposed child--to breast feed or not?

Authors:  Anju Seth
Journal:  Indian J Pediatr       Date:  2012-03-01       Impact factor: 1.967

5.  HIV and reproductive healthcare in pregnant and postpartum HIV-infected women: adapting successful strategies.

Authors:  Bassam H Rimawi; Somer L Smith; Martina L Badell; Leilah D Zahedi-Spung; Anandi N Sheth; Lisa Haddad; Rana Chakraborty
Journal:  Future Virol       Date:  2016-08-05       Impact factor: 1.831

Review 6.  Breast is best for babies.

Authors:  Alexander K C Leung; Reginald S Sauve
Journal:  J Natl Med Assoc       Date:  2005-07       Impact factor: 1.798

7.  Temporal changes in the outcomes of HIV-exposed infants in Kinshasa, Democratic Republic of Congo during a period of rapidly evolving guidelines for care (2007-2013).

Authors:  Lydia Feinstein; Andrew Edmonds; Jean Lambert Chalachala; Vitus Okitolonda; Jean Lusiama; Annelies Van Rie; Benjamin H Chi; Stephen R Cole; Frieda Behets
Journal:  AIDS       Date:  2014-07       Impact factor: 4.177

8.  Maternal cocaine use during breastfeeding.

Authors:  Alex M Cressman; Gideon Koren; Anna Pupco; Eunji Kim; Shinya Ito; Pina Bozzo
Journal:  Can Fam Physician       Date:  2012-11       Impact factor: 3.275

9.  Risk factors for late postnatal transmission of human immunodeficiency virus type 1 in sub-Saharan Africa.

Authors:  Charles Chasela; Ying Qing Chen; Susan Fiscus; Irving Hoffman; Alicia Young; Megan Valentine; Lynda Emel; Taha E Taha; Robert L Goldenberg; Jennifer S Read
Journal:  Pediatr Infect Dis J       Date:  2008-03       Impact factor: 2.129

10.  Evaluation and treatment of the human immunodeficiency virus-1-exposed infant.

Authors: 
Journal:  Paediatr Child Health       Date:  2004-07       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.